CAITLIN ANNE MURPHY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BOSTON, MA NPI 1689185282

General Payments — all program years on this page

$15,757.34

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,735.78 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,497.502
Travel and Lodging $815.455
Food and Beverage $422.837

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Genmab U.S., Inc. $3,576.5312
Lilly USA, LLC $109.501
Acerta Pharma LLC $49.751

By program year

Program yearAmountRecords
2021 $1,877.003
2022 $2,849.207
2023 $7,295.3626
2024 $3,735.7814

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104428217 AstraZeneca Pharmaceuticals LP $49.75 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834588 Genmab U.S., Inc. $40.00 03/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126834590 Genmab U.S., Inc. $36.92 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834592 Genmab U.S., Inc. $28.43 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834594 Genmab U.S., Inc. $31.04 03/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126834596 Genmab U.S., Inc. $392.06 03/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126834598 Genmab U.S., Inc. $252.35 03/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126834600 Genmab U.S., Inc. $1,417.50 03/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1126834602 Genmab U.S., Inc. $100.00 03/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126834604 Genmab U.S., Inc. $47.36 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834606 Genmab U.S., Inc. $16.14 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834608 Genmab U.S., Inc. $134.73 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126834610 Genmab U.S., Inc. $1,080.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135573176 Lilly USA, LLC $109.50 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.